Skip to main content Help with accessibility Skip to main navigation

Tapentadol Modified Release

Indication

Pain in the non-palliative care setting

Black

Brand:

Palexia SR

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Central nervous system

Background

Tapentadol MR is NOT recommended for use by the NHS in Lancashire and South Cumbria in the following settings:
• as a treatment option for intractable neuropathic pain in non-palliative care patients.
• as a treatment for nonspecific pain
There is insufficient evidence to consistently demonstrate improved efficacy in the above settings when compared to opioid drugs and there is a lack of significant evidence to demonstrate efficacy in patients inadequately controlled on opioid drugs.

*FOR WEST LANCASHIRE CCG ONLY* Tapentadol is commissioned in accordance with the Pan Mersey formulary

Recommendation

LSCMMG Recommendation:

Black

Reason for decision:

Not recommended for prescribing on the NHS in Lancashire & South Cumbria

Decisions of Lancashire local decision making groups

Black
Pending
Black
Black
Pending
Black
Black
Amber 0
What do the colours mean?

Last Updated: 10 - Dec - 2019